• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>GlaxoSmithKline

GlaxoSmithKline

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Medidata Collaborates with GlaxoSmithKline on Mobile Health Initiative to Test Novel Technology for Clinical Trial Optimization

    Medidata Collaborates with GlaxoSmithKline on Mobile Health Initiative to Test Novel Technology for Clinical Trial Optimization

  2. GlaxoSmithKline Files Regulatory Submissions in U.S., Europe For Mepolizumab

    GlaxoSmithKline Files Regulatory Submissions in U.S., Europe For Mepolizumab

  3. Ebola vaccine from Glaxo passes early trials

    Ebola vaccine from Glaxo passes early trials

  4. Novartis to Divest Nicotine Patch Habitrol to Comply with FTC

    Novartis to Divest Nicotine Patch Habitrol to Comply with FTC

  5. Ebola Vaccine Appears Safe in Early Test -- Update

    Ebola Vaccine Appears Safe in Early Test -- Update

  6. Ebola Vaccine Appears Safe in Early Test -- Update

    Ebola Vaccine Appears Safe in Early Test -- Update

  7. Ebola Vaccine Seems Safe, Triggers Immune Response in Early Test

    Ebola Vaccine Seems Safe, Triggers Immune Response in Early Test

  8. Ebola Vaccine Appears Safe in Early Test

    Ebola Vaccine Appears Safe in Early Test

  9. Research and Markets: PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023 for the $23 Billion Industry

    Research and Markets: PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023 for the $23 Billion Industry

  10. Research and Markets: Global Hospital Acquired Pneumonia Drugs Pipeline Analysis - 2014 Global Industry Analysis

    Research and Markets: Global Hospital Acquired Pneumonia Drugs Pipeline Analysis - 2014 Global Industry Analysis

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.